Programmed death of T cells has been proposed as one of the mechanisms by which HIV affects immune functions in stages of infection where the number of infected cells is low. Indeed, in HIV-infected individuals both CD4' and CD8' T cells are primed for programmed cell death, which can be enhanced by polyclonal stimulation. Here, we investigated programmed death of T cells in all stages of HIV infection, including acute infection. In individuals with primary infection the number of T cells dying due to apoptosis was much higher than in the asymptomatic phase of infection and paralleled increased numbers of CD8+ cells. In asymptomatic HIV-infected individuals, cells were dying in increased percentages compared with noninfected controls, although at much lower numbers than during acute infection. Death of T cells was not quantitatively correlated with CD4' T cell numbers or appearance of more cytopathic, syncytium-inducing HIV variants. Analysis of the phenotype of cells undergoing apoptosis revealed that cell death was not confined to a specific T cell subset nor correlated with expression of certain T cell activation markers. Our results imply that the extent of programmed cell death of T cells in HIV infection does not correlate with progression to disease. (J. Clin. Invest. 1994.93:982-988.)
Introduction
In the asymptomatic phase of HIV infection, immunological abnormalities can be demonstrated already before CD4 + T cell numbers start to decline. Both CD4' and CD8+ T cell functions, such as IL-2 production and proliferation after stimulation with recall antigens and CD3 antibodies, are affected (1) (2) (3) (4) (5) . The mechanism by which HIV is capable of affecting immune function in a stage of infection where the number of infected cells is low (6, 7) remains to be elucidated.
It has been proposed that T cells in HIV-infected individuals are programmed for death and that upon activation they will die due to apoptosis (8) . Indeed, recent results from our Receivedfor publication 31 August 1993 and in revisedform 2 November 1993. group and others (9-1 1 ) demonstrated cell death by apoptosis of PBMC of HIV-infected individuals in vitro. Programmed cell death (PCD)' occurred in both CD4+ and CD8+ T cells and was enhanced by activation in vitro (9, 1 1 ).
In HIV-infected chimpanzees that do not develop clinical symptoms, the proportion ofT cells dying due to PCD does not exceed that in noninfected animals ( 1 1, 12 ). This could imply either a function for PCD in HIV pathogenesis in humans, or that PCD is a reflection of immunopathogenic events. It has been suggested that interaction of soluble gp 120 with CD4 could prime T cells for PCD (8) . Cross-linking of bound gp 120 on human CD4+ T cells followed by signaling through the TCR results in apoptosis in vitro ( 13) . This, however, can not explain death of CD8 + T cells (9, 1 1). CD8 + T cells from HIV-infected individuals have increased expression of activation markers, such as CD38, HLA-DR, and CD57, suggesting continuous immune activation ( 14, 15 ) . CD8 + cells expressing activation markers have severely decreased proliferative responses and clonogenic potential ( 16) and are reported to die in culture ( 17) .
PCD of T cells has been described in acute lymphocytic choriomeningitis virus (LCMV) infection in mice ( 1 8), correlating with hyporesponsiveness as a result ofhyperactivation of T cells in vivo. Similar findings have been reported for EpsteinBarr virus infection in humans ( 19, 20) , where both CD4+ and CD8 + cells die upon culture. Dying cells were confined to the CD45RO+ population and cell death could be prevented by culture in the presence of cytokines like IL-2 (20) . Also in that condition, PCD was suggested to affect the population of activated T cells that expands during the acute phase of the infection.
We investigated the occurrence of PCD in sequential stages of HIV infection. PCD was studied in primary infection and in the asymptomatic phase of infection in relation to CD4+ and CD8+ T cell counts. Moreover, PCD was studied in longitudinal samples from individuals followed from seroconversion until AIDS. Finally, the phenotype of cells undergoing PCD and the influence ofthe addition ofgrowth factors in vitro were studied.
Methods mAbs. The mAbs CLB-T3/4.E (CD3) (21) and CLB-CD19 (CD19) were produced at the Central Laboratory ofthe Netherlands Red Cross Blood Transfusion Service (Amsterdam, The Netherlands). UCHL1 (CD45RO) was a generous gift of Dr. P. Beverly (University College, London, UK) and UCHL1-FITC was purchased from Dakopatts (Glostrup, Denmark). 2H4, 2H4-FITC, and 2H4-phycoerythrin (PE) (CD45RA) mAbs were purchased from Coulter Immunology (Hia-leah, FL), and labeled antibodies against CD38, HLA-DR, and CD57 (Leu-17-PE, HLA-DR-PE, and Leu-7-FITC) from Becton Dickinson & Co. (Sunnyvale, CA).
Subjects. Three male and one female were studied early after virus transmission. Samples were taken frequently around the time of seroconversion and at longer intervals in the weeks thereafter. All four individuals presented clinical symptoms of acute infection as described (22) . For studies on the asymptomatic phase of HIV infection, participants of the Amsterdam cohort study on HIV infection in homosexual men (23) were studied transsectionally by analyzing freshly isolated cells and retrospectively by use of cryopreserved cells.
Cells. PBMC were isolated by Ficoll-Paque density gradient centrifugation from heparinized blood and directly used or cryopreserved as indicated. Viable cells were preserved in liquid nitrogen and cryopreservation did not markedly influence the percentages ofcells in apoptosis. For some experiments cells were purified by either cell separation or sorting techniques. Cells ( 106) were then cultured in I ml Iscove's modification of Dulbecco's medium (IMDM) supplemented with 10% FCS (in the absence or presence of CD3 mAb CLB-T3/4.E [21] ). In experiments indicated, growth factors were added in culture, and after overnight culture, cells were harvested and DNA fragmentation was examined by gel electrophoresis or in situ nick translation.
The following T cell growth factors were used: 50 U/ml rIL-2 and/ or 5 ng/ml rIL-la (both obtained from Hoffman-La Roche, Nutley, NJ) or 10% of the enriched supernatant of Con A-activated healthy donor PBMC. To generate this supernatant, pooled PBMC from 10 healthy donors were cultured in IMDM containing 10% FCS and 1 ng/ml PMA. After 24 h 5 mg/ml Con A was added and 48 h thereafter the supernatant was harvested and showed to contain 680 U/ml IL-2 and 60 ng/ml IFN-y.
Cell (25) . Cells were lysed with 0.5 ml hypotonic lysis buffer (10 mM Tris, 1 mM EDTA, 0.2% Triton X-100). The lysates were immediately centrifuged at 13,000 g for 10 min and the supernatant, containing fragmented DNA, was collected. Proteins were removed by phenol-chloroform-isoamylalcohol extraction and DNA was precipitated overnight with a 1:20 vol 3 M NaAc and 2 vol 96% ethanol at -20°C. In experiments in which the cells were counterstained with PE-labeled mAb directed against CD45RA, CD45RO, CD38, or HLA-DR, cells were fixed in 2% paraformaldehyde ( 10 min, 0C), washed in PBS containing 5% pooled human serum and 1% BSA, and incubated for 10 min at 0C in 0.01% NP-40. The in situ nick translation was then performed as described above, thereby using 0.02% (vol/vol) Tween-20 in 20X SSC for washings. After incubation with avidin-FITC, cells were washed with PBS supplemented with 0.5% BSA. Cells were then incubated 30 min at 40C with PE-labeled mAb and washed twice before analysis on a FACScan0. Reproducible analysis with CD8-PE was not possible, since apoptotic cells lose expression of CD8 (data not shown).
Results
PCD increases in parallel with CD8' cell numbers in primary HIV infection. In primary HIV infection often a transient CD8 + lymphocytosis is observed, during which a high proportion of CD8+ cells expresses activation markers as CD38 and HLA-DR (22). Here, PCD was analyzed after overnight culture in samples obtained from four individuals early after HIV transmission. In Fig. 1 , percentages ofcells undergoing apoptosis as well as absolute CD4+ and CD8+ T cell numbers are shown. The individual presented in Fig. 1 A had an increase in CD8 + cell numbers that peaked around day 9 after seroconversion, associated with a high percentage ofcells in apoptosis (up to 58%). In the period thereafter the number ofcells dying due to PCD was in range with numbers of cells in PCD in asymptomatic HIV-infected individuals (9) . The DNA fragmentation pattern typical for PCD as observed 4 and 9 d after seroconversion is shown ( Fig. 1 A, inset) .
The patient described in Fig. I B did not display a marked increase in CD8+ cell numbers, and in concordance the percentages ofcells undergoing PCD, although above background values, were not exceedingly high. Fig. 1 C shows an individual in which CD8+ cell numbers were increased for a prolonged period of time. The high number of cells undergoing PCD had returned to levels normally observed in HIV-infected individuals only 78 d after seroconversion. Finally, the high proportion ofcells in apoptosis in the fourth patient was accompanied by increased but not extremely high CD8 + T cell numbers (Fig.  1 D) . In none of these patients was a correlation between the levels of p24 antigen in plasma or virus load in PBMC and the amount of cells in apoptosis observed (Koot, (5, 26) . A group of 52 asymptomatic HIV-infected men were stratified for absolute CD4 + and CD8 + T cell numbers. As shown in Fig. 2 A, CD4' T cell counts. A relation between PCD and decline in CD4+ cells was not found either (data not shown). Analysis of PBMC from four patients, sampled longitudinally during all stages of HIV infection from seroconversion to AIDS, showed no change in percentages of apoptotic cells over time (Fig. 3) . As demonstrated by the samples taken before seroconversion, which were available from two individuals, apoptosis increased after HIV infection but varied over time. Percentage apoptotic cells appeared not to be related to virus load, as determined by clonal virus isolation in these individuals (Koot, M., A. B. van't Wout, N. A. Kootstra, R. E. Y. de Goede, R. A. Coutinho, M. Tersmette, and H. Schuitemaker, manuscript in preparation). Phenotyping of the HIV variants isolated from these individuals demonstrated that all four had gone through a transition from non-syncytium-inducing (NSI) variants to SI variants during infection, which is known to correlate with an increased CD4+ T cell decline and progression to AIDS (26) . The number of apoptotic T cells in these four patients was not altered by the appearance of SI viruses, compatible with additional data on PCD in five individuals 6 and 3 mo before and 3 and 6 mo after NSI to SI conversion (data not shown).
In acute infection high percentages of PCD were related to high CD8+ cell counts. In agreement, in the asymptomatic phase of infection both PCD and CD8+ cell counts are decreased. In the asymptomatic phase CD8 + T cell numbers are steadily increasing over time. Since an association of high percentages of cells dying from PCD with increased numbers of CD8 + cells was observed in primary infection, we analyzed this relation in the asymptomatic group. In this relatively small range of CD8 + cell counts no correlation with PCD was found (Fig. 2 B) .
Phenotype ofcells undergoing PCD. HIV-infected individuals have increased numbers ofCD8 + T cells expressing activation markers CD38, HLA-DR, and CD57 (14, 15 culture. Despite the fact that a large proportion ofthe cells died in culture, the phenotype of remaining T cells was comparable to the freshly isolated cells, compatible with random cell death (Table I) . Second, PBMC from an asymptomatic HIV-infected individual and an HIV-negative control were depleted for either CD45RA+ or CD45RO+ cells by using mAb and anti-mouse IgG-coated magnetic beads, and cultured in the absence or presence of CD3 mAb. After overnight culture, DNA fragmentation evidenced by gel electrophoresis was observed in both T cell subsets (Fig. 4 A) . Third, PBMC from an asymptomatic HIV-infected individual were stained with CD45RA-PE and CD45RO-FITC, sorted on a FACStarO, and placed into culture in the absence or presence of CD3 mAb. After overnight culture, both populations died to the same extent, as determined by in situ nick translation (Fig. 4 B) . From these experiments it might be concluded that in PBMC from asymptomatically HIV-infected individuals the percentage of CD45RA+ and CD45RO+ cells dying from PCD is comparable.
Finally, we analyzed the phenotype of apoptotic cells from individuals both during primary and asymptomatic HIV infection. Analysis of the number of cells undergoing apoptosis as described in the previous experiments was performed by in situ nick translation. In this assay, apoptotic cells are visualized on a FACScang by incorporation of FITC-labeled nucleotides in (Fig. 5) . (30) described that while freshly isolated T cells from healthy individuals are resistant to PCD, the susceptibility ofthese cells for induced death increases upon activation and culture. In agreement with our observations in both primary and asymptomatic infection, in these experiments no correlation between susceptibility for death and the expression of a specific activation marker could be demonstrated (30) . PCD, both in these systems and in viral infection, might reflect turnover of cells, necessary to control and terminate an effective immune response. The exact mechanism by which in vivo activation leads to cell death remains to be clarified. The apoptosis-related Fas/APO-I antigen is known to be preferentially expressed on previously activated or memory T cells (31 ) . Interaction of Fas with its ligand might play a role by the elimination of excessive immune cells. Second, massive immune activation could lead to exhaustion of growth and survival factors and subsequently result in PCD. Our finding that growth factors in vitro could not prevent cells from HIV-infected individuals from dying does not exclude such a mechanism but could be due to the fact that cells from HIV-infected individuals are already irreversibly primed for PCD in vivo.
Recently, antigen-presenting cell (APC) function, regulating either proliferation and cytokine production or cell death ofthe responding T cell, was proposed as a mechanism to shape a given immune response (32) . We have previously argued that APC dysfunction as a result of HIV infection may cause T cell dysfunction (33) , which is also based on observations in HIV-infected chimpanzees. Chimpanzees can become persistently infected with HIV without development ofclinical symptoms. T cells ofHIV-infected chimpanzees have a normal response to stimulation in vitro and the proportion of T cells dying due to PCD in infected animals does not exceed that in noninfected animals (1 1, 12) . Interestingly, HIV does not infect chimpanzee monocytes and only T cell tropic variants are isolated from infected animals (12, 34, 35) . The (8) .
